Collagenase-derived peptides promote tissue regeneration and wound healing
US-2018339013-A1 · Nov 29, 2018 · US
Complement proteins, e.g. anaphylatoxin, C3a, C5a
Complement proteins, e.g. anaphylatoxin, C3a, C5a · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K14/472 |
| Official title | {Complement proteins, e.g. anaphylatoxin, C3a, C5a} |
| Display label | Complement proteins, e.g. anaphylatoxin, C3a, C5a |
| Total patents | 242 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2015 | 21 |
| 2016 | 20 |
| 2017 | 16 |
| 2018 | 21 |
| 2019 | 29 |
| 2020 | 18 |
| 2021 | 24 |
| 2022 | 24 |
| 2023 | 18 |
| 2024 | 25 |
| 2025 | 19 |
| 2026 | 7 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Chimeric inhibitor molecules of complement activation
US-2018273593-A1 · Sep 27, 2018 · US
Potent and highly soluble pegylated compstatin peptides
US-2018057538-A1 · Mar 1, 2018 · US
Methods and reagents for treatment of age-related macular degeneration
US-2017369543-A1 · Dec 28, 2017 · US
Humanized c5 animals
US-2017332611-A1 · Nov 23, 2017 · US
Masp isoforms as inhibitors of complement activation
US-2017334961-A1 · Nov 23, 2017 · US
Antibodies to the C3d fragment of complement component 3
US-9815890-B2 · Nov 14, 2017 · US
Chimeric inhibitor molecules of complement activation
US-9815876-B2 · Nov 14, 2017 · US
Potent compstatin analogs
US-2017305971-A1 · Oct 26, 2017 · US
Humanized C3 animals
US-9795121-B2 · Oct 24, 2017 · US
Nitrile hydratase
US-9738885-B2 · Aug 22, 2017 · US
Compstatin analogs with improved activity
US-2017190741-A9 · Jul 6, 2017 · US
Recombinant proteins having factor h activity
US-2017190753-A1 · Jul 6, 2017 · US
Chimeric inhibitor molecules of complement activation
US-2017166616-A1 · Jun 15, 2017 · US
Complement receptor 2 (CR2) targeting groups
US-9650447-B2 · May 16, 2017 · US
C1q-ADIPONECTIN COMPLEX AND USE THEREOF
US-2017082620-A1 · Mar 23, 2017 · US
Chimeric inhibitor molecules of complement activation
US-9573984-B2 · Feb 21, 2017 · US
Protein biomarkers for immune assessment and prediction of transplant rejection
US-2017030928-A1 · Feb 2, 2017 · US
Regulator of complement activation and uses thereof
US-9540626-B2 · Jan 10, 2017 · US
Anti-c5a antibodies
US-2016376357-A1 · Dec 29, 2016 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K14/472?
- CPC C07K14/472 is the Cooperative Patent Classification code for “Complement proteins, e.g. anaphylatoxin, C3a, C5a.”
- How many patents are filed under CPC C07K14/472 (Complement proteins, e.g. anaphylatoxin, C3a, C5a)?
- Our database includes 242 publications tagged with this CPC code.
- Is patent activity under CPC C07K14/472 growing?
- Publication counts under this code: 25 in 2024 vs 19 in 2025 (latest complete years).